Company Filing History:
Years Active: 2014
Title: Kathrin Kürschner: Innovator in Parvovirus Research
Introduction
Kathrin Kürschner is a notable inventor based in Heidelberg, Germany. She has made significant contributions to the field of virology, particularly in the development of antibodies targeting the H-1 parvovirus. Her work is crucial for improving diagnostic and therapeutic methods related to this virus.
Latest Patents
Kathrin Kürschner holds a patent for an antibody that binds to the H-1 parvovirus. This invention is particularly important as it addresses the detection and therapy of H-1 parvovirus infections during pregnancy. The H-1 parvovirus affects approximately 1 in 400 pregnancies and can lead to serious complications such as fetal loss or hydrops. The antibody or its antigen-binding fragment specifically targets the full or empty capsid of the virus, providing a valuable tool for medical professionals.
Career Highlights
Throughout her career, Kathrin has worked with prestigious institutions, including the German Cancer Research Center (Deutsches Krebsforschungszentrum). Her research has focused on the intersection of virology and immunology, leading to advancements in understanding viral infections and their implications for human health.
Collaborations
Kathrin has collaborated with esteemed colleagues such as Barbara Leuchs and Andrea Kuck. These partnerships have fostered a collaborative environment that enhances research outcomes and drives innovation in the field.
Conclusion
Kathrin Kürschner's contributions to parvovirus research exemplify the impact of innovative thinking in medicine. Her patent for an antibody targeting H-1 parvovirus is a testament to her dedication to improving health outcomes for pregnant individuals.